Join The Discussion

 

Two from Fort Worth appointed by Gov. Abbott to university boards

Steve Hicks, a University of Texas System regent who has been a vocal opponent of regents who have criticized the system’s flagship campus in Austin, was reappointed to the board by Gov. Greg Abbott on Thursday. 

read more >

Fort Worth draws closer to deal with Lancaster developer

City staff are planning to introduce the developer Feb. 3 at a meeting of the City Council's Housing and Economic Development Committee.

read more >

Compass BBVA names Happel CEO for Fort Worth

BBVA Compass has appointed Brian Happel, most recently the Fort Worth city president, its chief executive officer of Fort Worth.

read more >

Museum District: Area’s evolution creating more interaction, public spaces

Fifteen years ago if someone had shot a cannon from Fort Worth’s world-renowned museum district, nobody would have noticed, joked Lori Eklund, senior deputy director of the Amon Carter Museum of American Art. But that has changed.

read more >

Energy Transfer Partners, Regency Energy announce $18B merger

Energy Transfer Partners LP of Dallas and Regency Energy Partners LP have entered into a definitive merger agreement.

read more >

 

Fort Worth-area biotech firm seeks $86M IPO

Coppell-based ZS Pharma, a fomer TECH Fort Worth client, is looking to raise more funds with an $86 million initial public offering, the company said in a filing
The biotech firm recently raised $55 million from some venture capital groups a few weeks back. ZS Pharma is developing a drug treatments for hyperkalemia called ZS-9, a potentially life-threatenening medical condition in which kidneys are unable to excrete potassium.
Founded in 2008 in Indiana, ZS Pharma came to Texas to work with TECH Fort Worth and received a $2 million investment from the Texas Emerging Technology Firm.
JP Morgan Chase and Credit Suisee are the managers of the offering. ZS Pharma would trade on the NASDAQ Global Market under the symbol “ZSPH”.
 

< back

Email   email
hide
Catch
How 'bout them Cowboys?